# Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of ENV8058 (TAK-058) in Healthy Participants

> **NCT02153099** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 48 (actual)

## Conditions studied

- Dose Finding Study

## Interventions

- **DRUG:** TAK-058 (ENV8058)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02153099
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2015-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153099, "Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of ENV8058 (TAK-058) in Healthy Participants". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02153099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*